Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01924260
Title Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, Davis
Indications

pancreatic adenocarcinoma

Advanced Solid Tumor

Therapies

Alisertib + Gemcitabine

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.